FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

24120111000001106: Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
78693001000001119 Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78693101000001118 Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Is a Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Has active ingredient Lamivudine false Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Has active ingredient Zidovudine false Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Has specific active ingredient Lamivudine true Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Has specific active ingredient Zidovudine true Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) 60 tablet 6 x 10 tablets Has AMP True Zidovudine 300mg / Lamivudine 150mg tablets (Sandoz Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start